News Detail

Mumbai, 4 March 2025: AstraZeneca Pharma India Ltd on Monday said it has received approval from drug regulator CDSCO to import and distribute cancer treatment medicine Durvalumab solutions in the country.
The approval by the Central Drugs Standard Control Organisation ......
View Details
Source : AstraZeneca Pharma India Ltd
Cancer treatment medicine in India
AstraZeneca
cancer drugs
Medicine
Central Drugs Standard Control Organisation (CDSCO)
Related News
- First-ever NSQ Recall Policy by Karnataka (04-03-2025)
- 15 lakh units of substandard medicines given to patients: CAG Report (04-03-2025)
- Over 965 fake doctors traced in K'taka in 1.5 years (04-03-2025)
- Fake clinic running under the guise of medical store, large quantity of medicines seized (04-03-2025)
- Medical Store sealed after drug seizure in Ferozepur village (04-03-2025)
- DCC recommends upgradation of guidelines related to samples of spurious, NSQ drugs (03-03-2025)
- Tough to get details about drug manufacturers from other States: Kerala Drugs Control dept. (03-03-2025)
- CDSCO centralises GMP issuance and verification with new online portal (03-03-2025)
- Sirohi: Innocent died due to wrong injection, police arrested the quack; clinic seized (02-03-2025)
- Five women slip into delirium; anaesthesia drug reaction suspected (02-03-2025)